[3H]SCH 23390 labels a novel 5-hydroxytryptamine binding site in human blood platelet membranes
- 29 March 1989
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 162 (3) , 437-445
- https://doi.org/10.1016/0014-2999(89)90334-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- D1 dopamine receptors in human putamen, frontal cortex and calf retina: differences in guanine nucleotide regulation of agonist binding and adenylate cyclase stimulationBrain Research, 1988
- Identification of D1-like dopamine receptors on human blood plateletsLife Sciences, 1988
- Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranesJournal of Neuroscience, 1987
- D-1 dopamine receptors in the rat brain: a quantitative autoradiographic analysisJournal of Neuroscience, 1986
- Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatumEuropean Journal of Pharmacology, 1986
- 5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brainEuropean Journal of Pharmacology, 1984
- Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatumLife Sciences, 1984
- Inhibition of 5-hydroxytryptamine-induced and-amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonistInflammation Research, 1982
- THE BINDING OF HALOPERIDOL TO HUMAN BLOOD PLATELETS AND INTERACTIONS WITH 5‐HYDROXYTRYPTAMINE AND DOPAMINEBritish Journal of Pharmacology, 1978
- Effects of 5-Hydroxytryptamine on Platelet AggregationNature, 1968